AMRI NASDAQ
Albany Molecular Research, Inc.
1W: +0.1%
1M: +0.1%
3M: +7.8%
1Y: +46.7%
3Y: +12.6%
5Y: +550.9%
$21.74
Last traded 2017-08-31 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$681M
Revenue
+48.9% YoY
$-60M
Net Income
-77.3% YoY
$-17M
Free Cash Flow
-269.6% YoY
23.8%
Gross Margin
-0.9%
Op. Margin
-5.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-20.6%
ROA-5.8%
ROIC-1.8%
Valuation
P/E-13.2
P/B3.1
EV/EBITDA25.4
Leverage
Debt/Equity1.98
Current Ratio0.68
Interest Cov.-0.3x
Quality Scores
Piotroski F3/9
Altman Z0.90
Beneish M-2.15